Business Description
iSERA Lifesciences Ltd
ISIN : INE899M01020
Compare
Compare
Traded in other countries / regions
534920.India IPO Date
2013-02-06Description
iSERA Lifesciences Ltd, formally known as Covidh Technologies Ltd, is a technology services provider. The company provides IT and IT-enabled services. It derives revenue majorly from the sale of IT and IT-enabled services and Hardware.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.72 | |||||
Equity-to-Asset | 0.78 | |||||
Debt-to-Equity | 0.2 | |||||
Debt-to-EBITDA | 4.94 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 31.99 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year FCF Growth Rate | 84.1 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 100 | |||||
9-Day RSI | 100 | |||||
14-Day RSI | 100 | |||||
3-1 Month Momentum % | 83.83 | |||||
6-1 Month Momentum % | 404.07 | |||||
12-1 Month Momentum % | 4127 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 6.63 | |||||
Quick Ratio | 6.63 | |||||
Cash Ratio | 4.39 | |||||
Days Sales Outstanding | 164.08 | |||||
Days Payable | 1367.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1933.5 | |||||
Shareholder Yield % | -7.26 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 96.52 | |||||
Operating Margin % | 20.05 | |||||
Net Margin % | 19.14 | |||||
EBITDA Margin % | 24.83 | |||||
FCF Margin % | -395.14 | |||||
OCF Margin % | -395.14 | |||||
ROE % | 9.68 | |||||
ROA % | 5.7 | |||||
ROIC % | 6.18 | |||||
3-Year ROIIC % | 4.52 | |||||
ROC (Joel Greenblatt) % | 40.08 | |||||
ROCE % | 7.81 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 89.27 | |||||
PB Ratio | 14.67 | |||||
Price-to-Tangible-Book | 14.67 | |||||
EV-to-EBIT | 356.13 | |||||
EV-to-EBITDA | 356.13 | |||||
EV-to-Revenue | 88.41 | |||||
EV-to-FCF | -22.38 | |||||
Price-to-Projected-FCF | 37.77 | |||||
| Price-to-Net-Current-Asset-Value | 60.21 | |||||
| Price-to-Net-Cash | 218.03 | |||||
Earnings Yield (Greenblatt) % | 0.28 | |||||
FCF Yield % | -4.42 | |||||
Forward Rate of Return (Yacktman) % | -195.4 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
iSERA Lifesciences Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 13.55 | ||
| EPS (TTM) (₹) | -0.27 | ||
| Beta | -0.2426 | ||
| 3-Year Sharpe Ratio | 1.28 | ||
| 3-Year Sortino Ratio | 2.17 | ||
| Volatility % | 64.73 | ||
| 14-Day RSI | 100 | ||
| 14-Day ATR (₹) | 0.417409 | ||
| 20-Day SMA (₹) | 143.9 | ||
| 12-1 Month Momentum % | 4127 | ||
| 52-Week Range (₹) | 3.43 - 143.9 | ||
| Shares Outstanding (Mil) | 8.41 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
iSERA Lifesciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
iSERA Lifesciences Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| 0.003:1 Stock Split | 2024-03-22 | 676.67 (+0.00%) |
Show
Entries
iSERA Lifesciences Ltd Frequently Asked Questions
What is iSERA Lifesciences Ltd(BOM:534920)'s stock price today?
The current price of BOM:534920 is ₹143.90. The 52 week high of BOM:534920 is ₹143.90 and 52 week low is ₹3.43.
When is next earnings date of iSERA Lifesciences Ltd(BOM:534920)?
The next earnings date of iSERA Lifesciences Ltd(BOM:534920) is .
Does iSERA Lifesciences Ltd(BOM:534920) pay dividends? If so, how much?
iSERA Lifesciences Ltd(BOM:534920) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on iSERA Lifesciences Ltd
No articles.